| 1-P24 | Vulvar Intraepithelial Neoplasia: retrospective study of 10 years | Filipa Rafael | |
| 1-P19 | Comparison of visual and cytology cervical cancer screening in Maharashtra, India | Sara Vehling | |
| 1-P20 | Values of HPV status, sample margins, and endocervical curettement after LLETZ conization as prognostic factors for successful treatment | Ivana Stojanovic | |
| 1-P6 | Therapeutic human papillomavirus vaccines in head and neck cancer: A systematic review of current clinical trials | Katrine Schneider | |
| 1-P23 | High-grade vaginal intraepithelial neoplasia a retrospective study | Catarina Estevinho | |
| 1-P34 | Insights on HPV vaccination in the United States from mothers comments on facebook posts in a randomized trial | David Buller | |
| 1-P33 | Building collaborations among HPV vaccination stakeholders: examining the impact of a National HPV Roundtable | Virginia Dick | |
| 2-P1 | Analysis of human papillomavirus and DNA ploidy in cervical lesions | Adriane Pogere | |
| 2-P21 | The accuracy of colposcopy utilizing RCI or Swede score combined with adjunct hrHPV for prediction of high-grade intraepithelial neoplasia (CIN2) in the patients with ASC-US, ASC-H, LSIL and HSIL Pap smears on Bethesda classification | Pavol Zubor | |
| 2-P24 | CO2 laser treatment in VIN lesions: what is its role? | Isabel Pedrosa | |
| 2-P16 | DNA Methylation Panel for the Triage of HPV Positive Women in a Primary Screening Population. | Stephen Reynolds | |
| 3-P20 | Connection between the frequency of preventive gynecological examinations and cervical cancer detection: a case-control study | Platon Lopukhov | |
| 3-P23 | Melanoma maligno de vagina | Séfora Braga | |
| 3-P9 | New molecular markers in HPV infection risk stratification: systematic review | Carolina Monteiro | |
| 3-P22 | The role of HPV E6/E7 oncoproteins in early diagnostic of cervical precancerous lesions | Irina Jermakova | |
| 3-P12 | Detection of high risk HPV types and risk prediction of cervical cancer | Tarig Dafaalla | |
| 4-P36 | Results from ongoing trials of mobile Web apps to improve HPV vaccine uptake | Jeannyfer Reither | |
| 4-P10 | Accuracy of urinary human papillomavirus testing among women referred for treatment of cervical lesions: a technical pilot study | Maarit Leinonen | |
| 4-P27 | Absence of disruptive TP53 Mutations in high-risk human papillomavirus-driven neck squamous cell carcinoma from unknown primary | Paolo BOSCOLO-RIZZO | |
| 4-P30 | Retrospective cohort study of men who have sex with men that are infected by the human immunodeficiency virus and were submitted to human papillomavirus screening in the anal canal | Francisco VALE | |
| 4-P20 | Comparative performance of HPV DNA and messenger RNA tests in the post-leep test-of-cure setting | Darrel Cook | |
| 5-P22 | Genital prolapse associated with cervical cancer a case report | Catarina Estevinho | |
| 6-P12 | Could methylation assays for early detection of CIN2 lead to overtreatment? case report | Iolanda João Mora Cruz de Ferreira | |
| 6-P27 | Human papillomavirus infection in sino-nasal inverted papilloma: an Italian epidemiological study | Narcisa Muresu | |
| 7-P2 | Prevalence of human papillomavirus among adolescents after introduction of school-based HPV vaccination in Norway | Suzanne Campbell | |
| 8-P9 | Countries of Eastern Europe and Central Asia: the situation of HPV infection in HIV-positive women | Marina Deulina | |
| 9-P2 | Analysis of HPV 18 diversity among women with different morphology diagnosis in Russian Federation | Marina Dmitryukova | |
| 9-P22 | Evaluating ErbB receptor profile in young patients with cervical cancer | Georgios Michail | |
| 10-P2 | Prevalence of high-risk HPV in a region of Portugal: analysis of data from patients referred from cervical cancer screening | Sílvia Augusta Torres | |
| 10-P8 | Evaluation of a custom configured Tecan Evo Freedom worktable set up for pre-analytic processing of Preservcyt LBC samples for high risk HPV DNA testing in primary screening and triage | David Smith | |
| 10-P22 | Rhabdomyosarcoma of the cervix case report | Mihai MITRAN | |
| 11-P2 | Significant disparity in the prevalence of low-risk but not high-risk HPV genotypes among HIV positive MSMs as compared to healthy women | Wegene Borena | |
| 12-P8 | HPV and CMV infection among HIV-positive women in some countres of Eastern Europe and Central Asia | Anna Popova | |
| 14-P8 | Preliminary evaluation of the high low papillomastrip assay with Colli-PeeTM collected UCM preserved urine | Alex Vorsters | |
| 14-P2 | Identifying bias caused by multi-type HPV infections in type-specific progression parameter estimates | Anna Suomenrinne-Nordvik | |
2-5 December 2018 Lisbon

Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. |
||||
|
|